相似文献
1
Recent advances. Cardiology.
BMJ. 1998 Mar 21;316(7135):911-5. doi: 10.1136/bmj.316.7135.911.
2
[Cardiac insufficiency, cerebrovascular accidents and coronary disease: new enlightening].
Rev Med Suisse. 2013 Feb 27;9(375):482-3.
3
Recent advances in cardiology.
Postgrad Med J. 1994 Apr;70(822):257-74. doi: 10.1136/pgmj.70.822.257.
4
Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
Am Heart J. 2008 Sep;156(3):422-30. doi: 10.1016/j.ahj.2008.04.023. Epub 2008 Jul 11.
5
News from the 2002 Congress of the European Society of Cardiology: the Hotlines.
Circulation. 2002 Sep 10;106(11):e9021-8. doi: 10.1161/01.cir.0000036844.40992.40.
6
Recent advances in cardiology.
Postgrad Med J. 1992 May;68(799):327-37. doi: 10.1136/pgmj.68.799.327.
7
Primary Prevention of Sudden Cardiac Death.
JAMA. 2019 Jul 9;322(2):161-162. doi: 10.1001/jama.2019.7662.
8
Clinical, basic and populational science in cardiology: a report from the American Heart Association's 2007 scientific sessions.
Timely Top Med Cardiovasc Dis. 2007 Nov 26;11:E31.
9
The future of sudden cardiac death.
Ann Noninvasive Electrocardiol. 2009 Jan;14(1):1-3. doi: 10.1111/j.1542-474X.2008.00279.x.
10
Essays on citation classics in Cardiology.
Cardiology. 2014;127(4):263-4. doi: 10.1159/000357583. Epub 2014 Jan 31.
引用本文的文献
1
Trends in 1-year survival of people admitted to hospital in Ontario, 1994-2009.
CMAJ. 2013 Nov 5;185(16):E755-62. doi: 10.1503/cmaj.130875. Epub 2013 Sep 30.
本文引用的文献
1
Randomized, Placebo-Controlled Study of Lamifiban with Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: Rationale and Design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Study.
J Thromb Thrombolysis. 1995;2(3):165-169. doi: 10.1007/BF01062706.
2
Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.
Can J Cardiol. 1998 Aug;14(8):1045-53.
3
Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
Circulation. 1997 Aug 5;96(3):769-77. doi: 10.1161/01.cir.96.3.769.
4
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.
N Engl J Med. 1997 Jun 12;336(24):1689-96. doi: 10.1056/NEJM199706123362401.
5
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
Lancet. 1997 May 17;349(9063):1429-35.
6
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Lancet. 1997 Apr 5;349(9057):971-7. doi: 10.1016/s0140-6736(96)10488-8.
7
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Lancet. 1997 Mar 8;349(9053):675-82. doi: 10.1016/s0140-6736(96)08171-8.
8
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Lancet. 1997 Mar 8;349(9053):667-74. doi: 10.1016/s0140-6736(96)09145-3.
9
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Lancet. 1997 Mar 15;349(9054):747-52. doi: 10.1016/s0140-6736(97)01187-2.
10
The effect of digoxin on mortality and morbidity in patients with heart failure.
N Engl J Med. 1997 Feb 20;336(8):525-33. doi: 10.1056/NEJM199702203360801.
Zotero 插件